Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-23T17:16:52.933Z Has data issue: false hasContentIssue false

Suppression of gastric ulcer in mice by administration of Erigeron canadensis extract

Published online by Cambridge University Press:  30 August 2013

W. S. Park
Affiliation:
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea
J.-Y. Bae
Affiliation:
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea
M. S. Chun
Affiliation:
Korea Science Academy, Pusan, Republic of Korea
H. J. Chung
Affiliation:
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea
S. Y. Han
Affiliation:
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea
M.-J. Ahn
Affiliation:
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2013 

Erigeron canadensis (Conyza canadensis) is an annual or biennial herb, widely distributed all over the Korea. It is also known to be horseweed or Canadian horseweed, or butterweed in North America and Central America( Reference Pawlaczyk, Czerchawski and Kuliczkowski 1 ). Although this plant has been used as a folk medicine to treat allergic diarrhea, stomatitis, otitis media, conjunctivitis, and acute toothache, and its several biological activities such as anti-inflammatory, anticoagulant and anti-platelet activities have been reported, the effect of this plant on gastric ulcer has not been investigated( Reference Yan, Li and Zhao 2 ).

In our study, the 70% ethanolic extract (EEC) of the aerial parts of E. canadensis was found to protect the gastric ulcer induced by HCl/ethanol in mice. The administration of HCl/ethanol produced lesions on the gastric mucosa which were significantly and dose-dependently reduced from 74.4%, ulceration percentage to 14.4%, in the animals pretreated with this extract, p.o. at the doses of 1 (54.6±10.2 mm2), 10 (21.6±6.4 mm2) and 100 mg/kg (10.6±4.5 mm2) (Fig. 1).

Fig. 1. (A), normal stomach; (B), glandular stomach treated with vehicle; (C), the stomach of positive control group treated with sucralfate, 100 mg/kg, p.o.; (D∼F), the stomach of test groups treated with EC, 1, 10, and 100 mg/kg, p.o., respectively, 1 h before administration of 150 mM HCl/ethanol; (G) determination of the gastric ulcer area (mm2). Data are expressed as mean±s.e.m., n=6 to 10.

In case of the group pretreated with ECC at the dose of 100 mg/kg, the protective effect was higher than that of sucralfate used as a reference drug. Under histological evaluation, pre-treatment with EEC reversed the alterations such as inflammation, edema, moderate hemorrhage and a great loss of epithelium cells presented by HCl/ethanol treated stomachs, and the histological aspect was similar to those observed in normal stomach and the pretreated group with the reference drug.

EEC treatment decreased NO production in a murine macrophage cell line, Raw 264.7 in a dose-dependent manner as follows: 25, 40 and 64% reductions, respectively, at the concentrations of 1, 10 and 100 μg/ml. In addition, EEC did not affect on the cell viability and it showed potent DPPH radical scavenging activity.

This work was supported by grants from the Connected Cooperation Projects of Metropolitan Economic Areas (Grant # A004500005), Ministry of Knowledge Economy, Republic of Korea.

References

1. Pawlaczyk, I, Czerchawski, L, Kuliczkowski, W et al. (2011) Thromb Res 127, 328340.CrossRefGoogle Scholar
2. Yan, MM, Li, TY, Zhao, DQ et al. (2010) Chin Chem Lett 21, 834837.CrossRefGoogle Scholar
Figure 0

Fig. 1. (A), normal stomach; (B), glandular stomach treated with vehicle; (C), the stomach of positive control group treated with sucralfate, 100 mg/kg, p.o.; (D∼F), the stomach of test groups treated with EC, 1, 10, and 100 mg/kg, p.o., respectively, 1 h before administration of 150 mM HCl/ethanol; (G) determination of the gastric ulcer area (mm2). Data are expressed as mean±s.e.m., n=6 to 10.